Nora Grieb

Leipzig, SN, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Publisher Correction: Unsupervised risk factor identification across cancer types and data modalities via explainable artificial intelligence.

Publisher Correction: Unsupervised risk factor identification across cancer types and data modalities via explainable artificial intelligence.

Journal: NPJ digital medicine
Published: June 16, 2026

We included a total of 87 patients who received CAR T-cell therapy: 54 with none/mild chronic kidney disease (CKD) and 33 with moderate/severe CKD.

We included a total of 87 patients who received CAR T-cell therapy: 54 with none/mild chronic kidney disease (CKD) and 33 with moderate/severe CKD.

Journal: Transplantation and cellular therapy
Published: February 10, 2026

MyCARdiac score: integrating cardiac imaging and biomarkers to predict outcomes in RRMM patients receiving cilta-cel.

MyCARdiac score: integrating cardiac imaging and biomarkers to predict outcomes in RRMM patients receiving cilta-cel.

Journal: Leukemia
Published: October 14, 2025

Body composition predicts poor outcomes and reveals immunometabolic dysfunction via single-cell profiling in anti-BCMA CAR T-treated myeloma.

Body composition predicts poor outcomes and reveals immunometabolic dysfunction via single-cell profiling in anti-BCMA CAR T-treated myeloma.

Journal: HemaSphere
Published: September 11, 2025

Unsupervised risk factor identification across cancer types and data modalities via explainable artificial intelligence.

Unsupervised risk factor identification across cancer types and data modalities via explainable artificial intelligence.

Journal: NPJ digital medicine
Published: July 08, 2025

Publisher Correction: Predicting progression events in multiple myeloma from routine blood work.

Publisher Correction: Predicting progression events in multiple myeloma from routine blood work.

Journal: NPJ digital medicine
Published: May 28, 2025

Impact of cellular composition and T-cell senescence of mononuclear cell concentrates on the manufacturing process of chimeric antigen receptor (CAR) T-cells.

Impact of cellular composition and T-cell senescence of mononuclear cell concentrates on the manufacturing process of chimeric antigen receptor (CAR) T-cells.

Journal: Transfusion
Published: May 19, 2025

Prognostic Implications of Splenomegaly in BCMA-Directed CAR T-Cell Therapy for Relapsed Myeloma.

Prognostic Implications of Splenomegaly in BCMA-Directed CAR T-Cell Therapy for Relapsed Myeloma.

Journal: Transplantation and cellular therapy
Published: March 28, 2025

Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma.

Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma.

Journal: Bone marrow transplantation
Published: October 04, 2024

Predicting progression events in multiple myeloma from routine blood work.

Predicting progression events in multiple myeloma from routine blood work.

Journal: NPJ digital medicine
Published: June 19, 2024

A digital twin model for evidence-based clinical decision support in multiple myeloma treatment.

A digital twin model for evidence-based clinical decision support in multiple myeloma treatment.

Journal: Frontiers in digital health
Published: October 19, 2023

Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma.

Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma.

Journal: Leukemia
Published: September 28, 2023
Showing 1-12 of 18

Last Updated: 09/26/2026